348 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 7 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ADGRV1Adhesion G protein-coupled receptor V1
Group enriched6adrenal gland:56.5
cerebral cortex:29.1
ANKHANKH inorganic pyrophosphate transport regulator
CytosolGlioma: 7.64e-4
Expressed in all
CLCN2Chloride channel, voltage-sensitive 2
CytosolLiver cancer: 4.67e-8
Mixed
CLCN4Chloride channel, voltage-sensitive 4
VesiclesEndometrial cancer: 2.13e-5
Pancreatic cancer: 9.55e-4
Tissue enhancedcerebral cortex:49.2
epididymis:27.6
CLCN7Chloride channel, voltage-sensitive 7
NucleoplasmTestis cancer: 3.21e-4
Head and neck cancer: 5.23e-4
Expressed in all
CTNSCystinosin, lysosomal cystine transporter
Vesicles
Intermediate filaments
Pancreatic cancer: 6.39e-5
Head and neck cancer: 7.33e-4
Expressed in all
DIRC2Disrupted in renal carcinoma 2
VesiclesRenal cancer: 8.81e-11
Pancreatic cancer: 5.81e-5
Liver cancer: 7.48e-4
Expressed in all
EI24Etoposide induced 2.4
Endoplasmic reticulum
Golgi apparatus
Cytosol
Pancreatic cancer: 9.28e-4
Tissue enriched9parathyroid gland:1098.6
FLVCR1Feline leukemia virus subgroup C cellular receptor 1
Cell JunctionsRenal cancer: 1.06e-5
Liver cancer: 2.52e-5
Pancreatic cancer: 3.50e-4
Tissue enhancedsmall intestine:21.9
FLVCR2Feline leukemia virus subgroup C cellular receptor family, member 2
Renal cancer: 2.53e-5
Tissue enhancedtestis:38.5
HIATL1Hippocampus abundant transcript-like 1
Nucleoplasm
Cytosol
Expressed in all
HMGCR3-hydroxy-3-methylglutaryl-CoA reductase
Renal cancer: 9.42e-6
Expressed in all
LAPTM4BLysosomal protein transmembrane 4 beta
Golgi apparatusLiver cancer: 2.70e-6
Breast cancer: 5.63e-4
Head and neck cancer: 5.70e-4
Expressed in all
LAPTM5Lysosomal protein transmembrane 5
CytosolRenal cancer: 5.89e-5
Cervical cancer: 3.40e-4
Expressed in all
LETM1Leucine zipper-EF-hand containing transmembrane protein 1
MitochondriaProstate cancer: 1.77e-4
Liver cancer: 1.79e-4
Renal cancer: 8.90e-4
Expressed in all
MFSD2AMajor facilitator superfamily domain containing 2A
Plasma membrane
Cytosol
Cytoplasmic bodies
Renal cancer: 4.22e-6
Urothelial cancer: 2.33e-4
Tissue enhancedepididymis:114.6
seminal vesicle:109.6
MFSD6LMajor facilitator superfamily domain containing 6-likeN/A
Breast cancer: 1.84e-4
Tissue enhancedtestis:29.7
MFSD8Major facilitator superfamily domain containing 8
Nucleoplasm
Vesicles
Urothelial cancer: 2.21e-4
Expressed in all
MPC1Mitochondrial pyruvate carrier 1
MitochondriaRenal cancer: 4.79e-11
Lung cancer: 1.29e-4
Cervical cancer: 1.45e-4
Expressed in all
MPC2Mitochondrial pyruvate carrier 2
Expressed in all
MTCH1Mitochondrial carrier 1
Renal cancer: 1.16e-7
Liver cancer: 1.17e-4
Endometrial cancer: 2.06e-4
Expressed in all
MTCH2Mitochondrial carrier 2
MitochondriaRenal cancer: 9.05e-6
Expressed in all
NIPA1Non imprinted in Prader-Willi/Angelman syndrome 1
Tissue enhancedcerebral cortex:38.3
NIPA2Non imprinted in Prader-Willi/Angelman syndrome 2
Golgi apparatusExpressed in all
NIPAL3NIPA-like domain containing 3
NucleoplasmRenal cancer: 3.03e-7
Thyroid cancer: 3.95e-4
Expressed in all
NIPAL4NIPA-like domain containing 4
Urothelial cancer: 6.82e-4
Tissue enhancedskin:42.0
NPC1Niemann-Pick disease, type C1
Liver cancer: 2.26e-6
Expressed in all
NPC2Niemann-Pick disease, type C2
Colorectal cancer: 4.83e-5
Stomach cancer: 2.66e-4
Liver cancer: 3.13e-4
Thyroid cancer: 6.55e-4
Tissue enriched19epididymis:16057.0
OSBPL5Oxysterol binding protein-like 5
VesiclesMixed
OSBPL8Oxysterol binding protein-like 8
Vesicles
Cytosol
Pancreatic cancer: 9.79e-4
Expressed in all
OXA1LOxidase (cytochrome c) assembly 1-like
MitochondriaRenal cancer: 4.82e-4
Expressed in all
PQLC2PQ loop repeat containing 2
VesiclesLiver cancer: 2.64e-5
Endometrial cancer: 3.50e-4
Expressed in all
RFT1RFT1 homolog
VesiclesLiver cancer: 1.69e-4
Expressed in all
SFXN4Sideroflexin 4
VesiclesExpressed in all
SLC10A1Solute carrier family 10 (sodium/bile acid cotransporter), member 1
Liver cancer: 9.53e-6
Tissue enriched392liver:212.1
SLC10A2Solute carrier family 10 (sodium/bile acid cotransporter), member 2
Renal cancer: 5.78e-5
Group enriched32duodenum:21.6
kidney:15.3
small intestine:52.2
SLC10A3Solute carrier family 10, member 3
Intermediate filamentsColorectal cancer: 4.15e-5
Cervical cancer: 4.53e-4
Pancreatic cancer: 7.22e-4
Expressed in all
SLC10A4Solute carrier family 10, member 4N/A
Tissue enhancedadrenal gland:6.2
cerebral cortex:4.0
SLC10A5Solute carrier family 10, member 5N/A
Plasma membraneMixed
SLC10A7Solute carrier family 10, member 7N/A
NucleoliMixed
SLC11A1Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
Renal cancer: 2.58e-8
Tissue enhancedappendix:9.3
lung:13.2
SLC11A2Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
MitochondriaLung cancer: 3.07e-6
Expressed in all
SLC12A1Solute carrier family 12 (sodium/potassium/chloride transporter), member 1
Tissue enriched456kidney:773.2
SLC12A2Solute carrier family 12 (sodium/potassium/chloride transporter), member 2
Vesicles
Plasma membrane
Renal cancer: 7.09e-4
Endometrial cancer: 8.60e-4
Expressed in all
SLC12A3Solute carrier family 12 (sodium/chloride transporter), member 3
Tissue enriched107kidney:109.3
SLC12A4Solute carrier family 12 (potassium/chloride transporter), member 4
EndosomesRenal cancer: 2.25e-6
Expressed in all
SLC12A5Solute carrier family 12 (potassium/chloride transporter), member 5
Glioma: 8.45e-4
Tissue enriched8cerebral cortex:94.5
SLC12A6Solute carrier family 12 (potassium/chloride transporter), member 6
Vesicles
Cytosol
Renal cancer: 3.33e-6
Mixed
SLC12A7Solute carrier family 12 (potassium/chloride transporter), member 7
CytosolLiver cancer: 2.12e-6
Urothelial cancer: 3.16e-5
Mixed
SLC12A8Solute carrier family 12, member 8
NucleoplasmRenal cancer: 5.56e-4
Tissue enhancedthyroid gland:39.4

Page of 7 | next »